APP下载

新型四环素药物Eravacycline体外诱导金黄色葡萄球菌耐药16S rRNA基因突变位点分析

2019-09-29李桂秋魏影余治健陈俊文钟婉莹陈重

中国医学创新 2019年18期
关键词:耐药

李桂秋 魏影 余治健 陈俊文 钟婉莹 陈重

【摘要】 目的:研究Eravacycline體外诱导金黄色葡萄球菌耐药菌株的核糖体30S亚基16S rRNA基因和核糖体蛋白变异特点,阐明金黄色葡萄球菌Eravacycline耐药机制。方法:选择3株金黄色葡萄球菌株,采用Eravacycline不同压力浓度下逐渐诱导Eravacycline耐药金黄色葡萄球菌耐药菌株,挑取诱导菌株单克隆,采用琼脂平板稀释法测定母株及诱导系列的Tigecycline和Eravacycline的MIC值;通过PCR扩增其5个拷贝的16S rRNA基因(RR1-RR5)和30S核糖体蛋白基因,将诱导的Eravacycline耐药株扩增产物测序后与母株序列比较,获得该基因片段突变位点。结果:经过体外Eravacycline不同浓度梯度多步诱导共挑取6株Eravacycline耐药菌株,这些菌株的Tigecycline和Eravacycline的MIC值范围分别为8~16 μg/mL和32~64 μg/mL。16S rRNA基因PCR测序分析提示该基因的主要突变位点分别为RR1(T170G)、RR2(A1124G,G77A)、RR3(C810T)、RR4(G185A,G1036A),30S亚基核糖体蛋白S3蛋白没有突变,30S亚基核糖体蛋白S10基因多个位点突变。结论:金黄色葡萄球菌Eravacycline诱导耐药后可导致Tigecycline和Eravacycline的交叉耐药及16S rRNA基因和30S亚基核糖体蛋白S10位点突变。

【关键词】 MRSA; MSSA; Evacycline诱导耐药; 16S rRNA基因

Genetic Mutation of 16S rRNA Genes in Eravacycline-resistant Staphylococcus Aureus in Vitro Induced Under Eravacycline Pressure/LI Guiqiu,WEI Ying,YU Zhijian,et al.//Medical Innovation of China,2019,16(18):-146

【Abstract】 Objective:To study the mutation characteristics of ribosomal 30S subunit 16S rRNA gene and ribosomal protein in Staphylococcus aureus resistant strains induced by Eravacycline in vitro,to elucidate the resistance mechanism of Staphylococcus aureus Eravacycline.Method:3 strains of Staphylococcus aureus were selected to induce drug-resistant Staphylococcus aureus strains with Eravacycline at different pressure concentrations.Monoclones of the induced strains were selected.The MIC values of Tigecycline and Eravacycline in the mother strain and induction series were determined by agar plate dilution method.5 copies of the 16S rRNA gene(RR1-RR5)and 30S ribosomal protein gene were amplified by PCR.The amplified products of the induced Eravacycline resistant strain were sequenced and compared with the sequence of the parent strain to obtain the mutation site of the gene fragment.Result:6 strains of Eravacycline-resistant strains were selected by multi-step induction with different concentration gradients in vitro,the MIC values of Tigecycline and Eravacycline of these strains ranged from 8 to 16 μg/mL and 32 to 64 μg/mL respectively.PCR sequencing analysis of 16S rRNA gene indicated that the main mutation sites of the gene were RR1(T170G),RR2(A1124G,G77A),RR3(C810T),RR4(G185A,G1036A),30S subunit ribosomal protein S3 protein had no mutation,and 30S subunit ribosomal protein S10 gene had multiple mutations.Conclusion:After Staphylococcus aureus Eravacycline induced drug resistance can lead to cross-resistance of Tigecycline and Eravacycline,mutation of 16S rRNA gene and S10 site of 30S subunit ribosomal protein.

【Key words】 MRSA; MSSA; Evacycline resistance; 16S rRNA gene

First-authors address:Shenzhen Nanshan Peoples Hospital,Shenzhen 518052,China

doi:10.3969/j.issn.1674-4985.2019.18.038

金黄色葡萄球菌是G+细菌的代表菌,主要分布在人体皮肤表面、鼻咽部和肠道,该细菌通过内外毒素及免疫病理可引起呼吸系统、血流、伤口等组织化脓性感染[1-2]。耐甲西林耐药金黄色葡萄球菌(MRSA)是由mecA基因编码的一种pbp2A蛋白,此蛋白与甲氧西林亲和力低,该类细菌临床治疗选择极为有限,开发金黄色葡萄球菌治疗药物尤其是MRSA治疗的有效药物是临床的紧迫问题[1]。

四环素类抗生素作用于细菌核糖体30S亚基,体外晶体结构分析四环素的作用机制是与30S小亞基16S rRNA和核糖体蛋白相互作用,阻止氨基酰-tRNA转运从而干扰蛋白质合成[2-3]。……

登录APP查看全文

猜你喜欢

耐药
如何判断靶向治疗耐药
Ibalizumab治疗成人多耐药HIV-1感染的研究进展
miR-181a在卵巢癌细胞中对顺铂的耐药作用
铂耐药复发性卵巢癌的治疗进展
超级耐药菌威胁全球,到底是谁惹的祸?
婴幼儿感染中的耐药菌分布及耐药性分析
念珠菌耐药机制研究进展
无缝隙管理模式对ICU多重耐药菌发生率的影响
PDCA循环法在多重耐药菌感染监控中的应用
27株多重耐药铜绿假单胞菌的耐药谱和ERIC-PCR分型